Postpartum thyroiditis screening
Postpartum thyroiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Postpartum thyroiditis screening On the Web |
American Roentgen Ray Society Images of Postpartum thyroiditis screening |
Risk calculators and risk factors for Postpartum thyroiditis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
According to the American Journal of Obstetrics and Gynecology, screening for postpartum thyroiditis, done by measuring anti-TPO antibodies is recommended for every pregnant woman. According to the Endocrinology and Metabolism Clinics of North America, screening for postpartum thyroiditis in first trimester, by measuring anti-TPO antibodies, should be limited to every high-risk pregnant women with type 1 DM and history of postpartum thyroiditis. According to these recommendations, any patient with high risk of PPT should be followed with TSH levels in every 6th and 9th postpartum month.
Screening
- According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women.[1]
- According to the Endocrinology and Metabolism Clinics of North America screening for postpartum thyroiditis in first trimester by measuring anti-TPO antibodies should be limited to every high risk pregnant women with:[2]
- Type 1 DM
- History of postpartum thyroiditis
Any patient with high risk of PPT should be followed with TSH levels in every 6th and 9th postpartum month.[3]
References
- ↑ Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988). "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction". Am J Obstet Gynecol. 159 (1): 203–9. PMID 3394739.
- ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
- ↑ Keely EJ (2011). "Postpartum thyroiditis: an autoimmune thyroid disorder which predicts future thyroid health". Obstet Med. 4 (1): 7–11. doi:10.1258/om.2010.100041. PMC 4989649. PMID 27579088.